Westerkirk Capital Inc. Purchases Shares of 33,700 Zoetis Inc. $ZTS

Westerkirk Capital Inc. acquired a new position in shares of Zoetis Inc. (NYSE:ZTS) in the 2nd quarter, HoldingsChannel reports. The institutional investor acquired 33,700 shares of the company’s stock, valued at approximately $5,256,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Nova Wealth Management Inc. acquired a new position in shares of Zoetis in the 1st quarter valued at $25,000. 1248 Management LLC acquired a new stake in Zoetis during the 1st quarter worth about $27,000. Saudi Central Bank purchased a new stake in Zoetis during the first quarter valued at about $29,000. REAP Financial Group LLC lifted its stake in Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock valued at $31,000 after buying an additional 131 shares in the last quarter. Finally, NewSquare Capital LLC boosted its holdings in shares of Zoetis by 69.1% in the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock worth $32,000 after buying an additional 85 shares during the period. 92.80% of the stock is owned by institutional investors and hedge funds.

Zoetis Stock Down 0.7%

ZTS stock opened at $127.31 on Tuesday. The firm has a market cap of $56.11 billion, a PE ratio of 21.91, a PEG ratio of 2.31 and a beta of 0.90. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $181.85. The company has a fifty day simple moving average of $135.42 and a 200 day simple moving average of $148.74. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.08. The company had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business’s revenue was up .5% compared to the same quarter last year. During the same period last year, the company earned $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.6%. The ex-dividend date is Friday, October 31st. Zoetis’s dividend payout ratio (DPR) is 33.67%.

Analyst Ratings Changes

ZTS has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. cut their price target on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. KeyCorp assumed coverage on shares of Zoetis in a research report on Thursday, November 20th. They set a “sector weight” rating on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. BTIG Research decreased their target price on Zoetis from $200.00 to $160.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Finally, Argus reiterated a “buy” rating and set a $190.00 price target on shares of Zoetis in a report on Tuesday, September 9th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Zoetis currently has an average rating of “Moderate Buy” and a consensus target price of $178.89.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.